{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:00:44Z","timestamp":1791115244405,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["Z01 ES101074"],"award-info":[{"award-number":["Z01 ES101074"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis Care &amp;amp; Research"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Because juvenile idiopathic inflammatory myopathies (IIMs) are potentially life\u2010threatening systemic autoimmune diseases, we examined risk factors for juvenile IIM mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Mortality status was available for 405 patients (329 with juvenile dermatomyositis [DM], 30 with juvenile polymyositis [PM], and 46 with juvenile connective tissue disease\u2013associated myositis [CTM]) enrolled in nationwide protocols. Standardized mortality ratios (SMRs) were calculated using US population statistics. Cox regression analysis was used to assess univariable associations with mortality, and random survival forest (RSF) classification and Cox regression analysis were used for multivariable associations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 17 deaths (4.2% overall mortality), 8 (2.4%) were in juvenile DM patients. Death was related to the pulmonary system (primarily interstitial lung disease [ILD]) in 7 patients, gastrointestinal system in 3, and multisystem in 3, and of unknown etiology in 4 patients. The SMR for juvenile IIMs overall was 14.4 (95% confidence interval [95% CI] 12.2\u201316.5) and was 8.3 (95% CI 6.4\u201310.3) for juvenile DM. The top mortality risk factors in the univariable analysis included clinical subgroup (juvenile CTM, juvenile PM), antisynthetase autoantibodies, older age at diagnosis, ILD, and Raynaud's phenomenon at diagnosis. In multivariable analyses, clinical subgroup, illness severity at onset, age at diagnosis, weight loss, and delay to diagnosis were the most important predictors from RSF; clinical subgroup and illness severity at onset were confirmed by multivariable Cox regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall mortality was higher in juvenile IIM patients, and several early illness features were identified as risk factors. Clinical subgroup, antisynthetase autoantibodies, older age at diagnosis, and ILD are also recognized as mortality risk factors in adult myositis.<\/jats:p><\/jats:sec>","DOI":"10.1002\/acr.22212","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T15:51:42Z","timestamp":1382370702000},"page":"732-740","source":"Crossref","is-referenced-by-count":80,"title":["Early Illness Features Associated With Mortality in the Juvenile Idiopathic Inflammatory Myopathies"],"prefix":"10.1002","volume":"66","author":[{"given":"Adam M.","family":"Huber","sequence":"first","affiliation":[{"name":"IWK Health Centre and Dalhousie University Halifax, Nova Scotia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnara","family":"Mamyrova","sequence":"additional","affiliation":[{"name":"George Washington University School of Medicine Washington DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Lachenbruch","sequence":"additional","affiliation":[{"name":"National Institute of Environmental Health Sciences, NIH Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Lee","sequence":"additional","affiliation":[{"name":"National Institute of Environmental Health Sciences, NIH Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Katz","sequence":"additional","affiliation":[{"name":"George Washington University School of Medicine Washington DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira N.","family":"Targoff","sequence":"additional","affiliation":[{"name":"VAMC, University of Oklahoma Health Sciences Center, and Oklahoma Medical Research Foundation Oklahoma City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Miller","sequence":"additional","affiliation":[{"name":"National Institute of Environmental Health Sciences, NIH Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Rider","sequence":"additional","affiliation":[{"name":"National Institute of Environmental Health Sciences, NIH Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Childhood Myositis Heterogeneity Collaborative Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60955-1"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31827f264d"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31829d08f9"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-1164-z"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.045690"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000109755.65914.5e"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10595.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02406.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.09.008"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-143"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600622603"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-012-0673-2"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101002"},{"key":"e_1_2_7_15_1","first-page":"S109","article-title":"Mortality in idiopathic inflammatory myopathies","volume":"26","author":"Lundberg IE","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(64)80325-5"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2012.03.006"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27218"},{"key":"e_1_2_7_19_1","first-page":"117","article-title":"Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis","volume":"29","author":"Guseinova D","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel099"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"e_1_2_7_22_1","first-page":"1","article-title":"US decennial life tables for 1999\u20102001, United States life tables","volume":"57","author":"Arias E","year":"2008","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_2_7_23_1","volume-title":"Modeling survival data: extending the Cox model","author":"Therneau TM","year":"2010"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1214\/08-AOAS169"},{"key":"e_1_2_7_25_1","first-page":"25","article-title":"Random survival forests for R","volume":"7","author":"Ishwaran H","year":"2007","journal-title":"R News"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr217"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201100251"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.110.939371"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21695"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3704"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199111000-00002"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11484"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.22212","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.22212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:04:24Z","timestamp":1759421064000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.22212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1002\/acr.22212"],"URL":"https:\/\/doi.org\/10.1002\/acr.22212","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,22]]}}}